| 000 | 00949 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515113449.0 | ||
| 264 | 0 | _c20110714 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1176-6336 | ||
| 024 | 7 |
_a10.2147/tcrm.2007.3.2.225 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaber, Anna | |
| 245 | 0 | 0 |
_aIncidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. _h[electronic resource] |
| 260 |
_bTherapeutics and clinical risk management _cJun 2007 |
||
| 300 |
_a225-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aHeras, Joan | |
| 700 | 1 | _aCosta, Joan | |
| 700 | 1 | _aFortea, Josep | |
| 700 | 1 | _aCobos, Albert | |
| 773 | 0 |
_tTherapeutics and clinical risk management _gvol. 3 _gno. 2 _gp. 225-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/tcrm.2007.3.2.225 _zAvailable from publisher's website |
| 999 |
_c17861340 _d17861340 |
||